Try our beta test site

A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by Rgenix, Inc.
Sponsor:
Information provided by (Responsible Party):
Rgenix, Inc.
ClinicalTrials.gov Identifier:
NCT02922764
First received: September 29, 2016
Last updated: December 1, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2019
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)